UC researchers receive FDA grant to study generic tacrolimus in high-risk ... News-Medical.net Tacrolimus is a "cornerstone drug" in post-transplant immunosuppression, used after transplant to reduce the activity of the patient's immune system and lower the risk of rejection. Generic versions were introduced in 2009. Currently Alloway estimates ... $2.3M grant to University of Cincinnati could help organ transplant patients |
